Verbal Autopsy to Assess Early Neonatal Death and Stillbirth
NCT ID: NCT00640055
Last Updated: 2014-07-31
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE4
200 participants
INTERVENTIONAL
2007-07-31
2008-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
This study uses a validated VA questionnaire to determine COD of stillbirths and early neonatal deaths among participants in the FIRST BREATH study. We propose to expand the usefulness of perinatal verbal autopsy methodology in two ways. First by assessing whether the Community Coordinator (a non-physician health worker) can assign COD with a high level of concordance comparable to a Physician Panel, and second, whether the FIRST BREATH Birth Attendant can provide as reliable perinatal information as the mother during the VA interview. Our primary hypothesis is that the COD assigned by the FIRST BREATH Community Coordinator will be the same as the COD assigned by the Physician Panel in greater than 70% of early neonatal deaths (ENDs), when both use the same VA and FIRST BREATH data.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
First Breath: Neonatal Resuscitation in Developing Countries
NCT00136708
Neonatal Resuscitation in Zambia
NCT00097097
Mobile Virtual Simulation Training in Essential Newborn Care for Healthcare Workers in Low and Middle Income Countries
NCT05551312
Aspiration of Residual Gastric Contents
NCT01863043
Newborn Heart Rate as a Catalyst for Improved Survival
NCT03799861
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
SINGLE_GROUP
DIAGNOSTIC
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1
Coordinator (non-physician)
Coordinator
Coordinator (non-physician) assigned cause of death
2
Physician
Physician-assigned cause of death
Physician (gold standard) cause of death
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Coordinator
Coordinator (non-physician) assigned cause of death
Physician-assigned cause of death
Physician (gold standard) cause of death
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Lives in study cluster
Exclusion Criteria
* Delivery in hospital setting
7 Days
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
NICHD Global Network for Women's and Children's Health
NETWORK
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Marion Koso-Thomas, MD
Role: STUDY_DIRECTOR
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Cyril Engmann
Role: PRINCIPAL_INVESTIGATOR
UNC at CHapel Hill
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
San Carlos University
Guatemala City, , Guatemala
Aga Khan University
Karachi, , Pakistan
Kinshasa School of Public Health
Kinshasa, , Republic of the Congo
University of Zambia
Lusaka, , Zambia
Countries
Review the countries where the study has at least one active or historical site.
Related Links
Access external resources that provide additional context or updates about the study.
Global Network
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CP03
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.